BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8776959)

  • 1. De medicamenteuze behandeling van chronisch obstructieve longziekte [Drug treatment of chronic obstructive lung disease.
    Cabolet P
    Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1705. PubMed ID: 8776959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of chronic phase in chronic obstructive pulmonary disease].
    Kawashiro T
    Nihon Naika Gakkai Zasshi; 1995 May; 84(5):735-9. PubMed ID: 7616083
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucolytics: when dispensable, when necessary?
    Dorow P
    Lung; 1990; 168 Suppl():622-6. PubMed ID: 2117172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is systemic administration of N-acetylcysteine effective?].
    Gillissen A
    Dtsch Med Wochenschr; 2003 Mar; 128(12):632. PubMed ID: 12649804
    [No Abstract]   [Full Text] [Related]  

  • 5. [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators].
    Chikina SIu; Iagmurov BKh; Kopylev ID; Soodaeva SK; Chuchalin AG
    Ter Arkh; 2002; 74(3):62-5. PubMed ID: 11980127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchological treatment of chronic nonspecific lung diseases with bronchospastic syndrome].
    Tatlimuratov KT
    Ter Arkh; 1981; 53(3):103-6. PubMed ID: 7256598
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral N-acetylcysteine: how does it act?
    Richardson P
    Eur J Respir Dis; 1987 Feb; 70(2):71-2. PubMed ID: 3817073
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
    van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-acetylcysteine on the lung histopathology and oxidant-antioxidant status in rabbits exposed to cigarette smoke.
    Sezer M; Fidan F; Unlü M; Sahin O; Esme H; Köken T
    Tuberk Toraks; 2006; 54(2):144-51. PubMed ID: 16924570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylcysteine is unlikely to reduce hospitalisation for chronic obstructive pulmonary disease.
    Ernst P; Suissa S
    Eur Respir J; 2003 Nov; 22(5):865; author reply 865-6. PubMed ID: 14621098
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of N-acetylcysteine in the treatment of chronic obstructive pulmonary disease.
    van Herwaarden CL; Bast A; Dekhuijzen PN
    Neth J Med; 1995 Aug; 47(2):45-8. PubMed ID: 7566280
    [No Abstract]   [Full Text] [Related]  

  • 12. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.
    Gerrits CM; Herings RM; Leufkens HG; Lammers JW
    Eur Respir J; 2003 May; 21(5):795-8. PubMed ID: 12765423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine for chronic obstructive pulmonary disease?
    Lavietes MH
    Respiration; 1999; 66(6):491-2. PubMed ID: 10847827
    [No Abstract]   [Full Text] [Related]  

  • 14. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
    Mateos-Corral D; Cutz E; Solomon M; Ratjen F
    Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaphylactic reaction to N-acetylcysteine after poisoning with paracetamol].
    Stavem K
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2038-9. PubMed ID: 9235683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods of evaluation of expectorants and mucolytics--measurement of lung function.
    Bake B
    Eur J Respir Dis Suppl; 1980; 110():209-16. PubMed ID: 6938384
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peroral therapy with expectorants].
    Lunichkina IV; Solopov VN
    Klin Med (Mosk); 1988 Dec; 66(12):59-62. PubMed ID: 3230852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
    Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
    Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with inhalation corticosteroids: useful or useless in chronic obstructive pulmonary disease (COPD)?].
    van Schayck CP
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):778-80. PubMed ID: 10347639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.